NCT01655056View on ClinicalTrials.gov

A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
PharmacokineticsPharmacodynamicsHealthy SubjectsCaucasianJapanese
Interventions
DRUG

YM150

oral

DRUG

Placebo

oral

Trial Locations (1)

41460

FOCUS Clinical Drug Development GmbH, Neuss

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT01655056 - A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body | Biotech Hunter | Biotech Hunter